{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-003135","form_type":"8-K","ticker":"AWHL","cik":"0000926617","company_name":"Aspira Women's Health Inc.","filed_at":"2025-04-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.852895+00:00","generated_at":"2026-05-23T19:17:53.261068+00:00","sec_items":["1.01","3.02","5.02","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Aspira Women's Health raises up to $2M via discounted equity; appoints three new directors","bullets":["Equity purchase agreement with Triton Funds for up to $2M; first tranche 354,988 shares for $25,000.","Subsequent purchases priced at 75% of lowest 5-day trading price before closing.","Proceeds for commercial activities and working capital; subject to Nasdaq 19.99% limitation.","Appointed new directors: Dr. Jeffrey Cohen, John Fraser, Cynthia Hundorfean (eff. Apr 2-6, 2025).","Julie Carrillo appointed interim Principal Accounting Officer; Dr. Celeste Fralick departed Board."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-003135","json":"https://secwatch.observer/filing/0001641172-25-003135.json","markdown":"https://secwatch.observer/filing/0001641172-25-003135.md","text":"https://secwatch.observer/filing/0001641172-25-003135.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/926617/000164117225003135/0001641172-25-003135-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/926617/000164117225003135/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T19:17:53.261068+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0d1292c66a","claim":"Cynthia Hundorfean was appointed as director at Aspira Women's Health Inc..","evidence_excerpt":"On April 6, 2025, the Board appointed John Fraser and Cynthia Hundorfean as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225003135/0001641172-25-003135-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}]},{"claim_id":"59ffd721f3","claim":"John Fraser was appointed as director at Aspira Women's Health Inc..","evidence_excerpt":"On April 6, 2025, the Board appointed John Fraser and Cynthia Hundorfean as directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225003135/0001641172-25-003135-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}]},{"claim_id":"c533afb7fa","claim":"Jeffrey Cohen was appointed as director at Aspira Women's Health Inc..","evidence_excerpt":"On April 2, 2025, the Board (the “Board”) of Directors of the Company appointed Jeffrey Cohen, M.D. as a director of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225003135/0001641172-25-003135-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}]},{"claim_id":"df32efb729","claim":"Julie Carrillo was appointed as Principal Accounting Officer at Aspira Women's Health Inc..","evidence_excerpt":"On April 4, 2025, the Board appointed Julie Carrillo, the Company’s Corporate Controller, to act as the Principal Accounting Officer of the Company on an interim basis.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/926617/000164117225003135/0001641172-25-003135-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Principal Accounting Officer"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}